Literature DB >> 28054606

CRISPR-Cas9: A European position on genome editing.

François Hirsch1, Yves Lévy1, Hervé Chneiweiss2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28054606     DOI： 10.1038/541030c

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  CRISPR, the disruptor.

Authors:  Heidi Ledford
Journal:  Nature       Date:  2015-06-04       Impact factor: 49.962

Review 2.  Germline genome-editing research and its socioethical implications.

Authors:  Tetsuya Ishii
Journal:  Trends Mol Med       Date:  2015-06-12       Impact factor: 11.951
  2 in total
  4 in total

1.  Genome Editing: Promoting Responsible Research.

Authors:  François Hirsch; Christine Lemaitre; Hervé Chneiweiss; Lluis Montoliu
Journal:  Pharmaceut Med       Date:  2019-06

2.  Gene editing using CRISPR-Cas9 for the treatment of lung cancer.

Authors:  Andres Castillo
Journal:  Colomb Med (Cali)       Date:  2016-12-30

3.  THE GORDON WILSON LECTURE: THE ETHICS OF HUMAN GENOME EDITING.

Authors:  Barry S Coller
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

4.  Ethical implications of fighting malaria with CRISPR/Cas9.

Authors:  Maria Patrão Neves; Christiane Druml
Journal:  BMJ Glob Health       Date:  2017-08-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.